2016 International Congress Archives - Page 91 of 207

Glucagon-like peptide 1 analogues for treating multiple system atrophy: A translational study

F. Bassil, M.H. Canron, A. Vital, E. Bezard, Y. Li, N.H. Greig, P.O. Fernagut, W.G. Meissner (Bordeaux, France)
Glucocerebrosidase activity in a cohort of PD patients

I. Trezzi, V. Melzi, G. Franco, L. Borellini, E. Monfrini, A. Bordoni, N. Bresolin, G.P. Comi, A. Di Fonzo (Milan, Italy)
Glutathione status in Parkinson’s disease

L.K. Mischley (Kenmore, WA, USA)
Gray/white matter contrast loss correlates with clinical severity and visuospatial impairment in Parkinson’s disease patients

C. Uribe, B. Segura, H.C. Baggio, M.J. Marti, F. Valldeoriola, Y. Compta, A.I. Garcia-Diaz, A. Campabadal, A. Abos, C. Junque (Barcelona, Spain)
Greater incidence of depressive symptoms in atypical parkinsonism: Importance of early screening

L. Almeida, B. Ahmed, R. Walz, S. De Jesus, A. Patterson, D. Martinez-Ramirez, D. Vaillancourt, D. Bowers, H. Ward, M.S. Okun, M. Armstrong, N. McFarland (Gainesville, FL, USA)
Grey matter atrophy associated with the progression of cognitive decline in Parkinson’s disease (PD)

M. Chondrogiorgi, L.G. Astrakas, A.K. Zikou, M.I. Argyropoulou, S. Konitsiotis (Ioannina, Greece)
Group climate in the voice therapy of patients with Parkinson’s disease

G.L.A. Diaféria, P.B. Takaki, G. Madazio, C. Pacheco, M.S. Behlau (São Paulo, Brazil)
Group meetings for newly diagnosed Parkinson’s disease patients and their spouses: A preliminary experience

N. Geva, A. Hilel, Y. Manor, S. Arad, A. Ezra, N. Giladi, T. Gurevich (Tel Aviv, Israel)
Gustatory function of patients with essential tremor and its correlation with olfactory and cognitive functions

M.G. Senol, H. Tekeli, M. Saglam, E. Arslanoglu (Istanbul, Turkey)
Hand skin temperature and its response to cooling in clinical differentiation of multiple system atrophy and Parkinson’s disease

S. Augustis, T. Fiesel, W.H. Jost (Kaunas, Lithuania)